Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Translational Breast Cancer Research Consortium"
Count: 26
Selected: 0
NCT02743910Monitoring Plasma Tumor DNA in Early-Stage Breast Cancer
NCT00577122Medroxyprogesterone +/- Cyclophosphamide & Methotrexate in Hormone Receptor-Negative Recurrent/Metastatic Breast Cancer
NCT06439693The SAPPHO Study: A Single-Arm, Phase II Study of Sequential Therapy With Curative Intent in de Novo HER2+ Metastatic Breast Cancer
NCT01494662HKI-272 for HER2-Positive Breast Cancer and Brain Metastases
NCT01937117Pertuzumab and Trastuzumab as Neoadjuvant Treatment in Patients With HER2-Positive Breast Cancer
NCT00999804Extension Study of Lapatinib Plus Herceptin With or Without Endocrine Therapy
NCT00977119Investigation of Genetic Determinants of Capecitabine Toxicity
NCT02384239A Study of Palbociclib in Combination With Fulvestrant or Tamoxifen as Treatment for Metastatic Breast Cancer
NCT04425018MARGetuximab Or Trastuzumab (MARGOT)
NCT01982448Cisplatin vs Paclitaxel for Triple Negative Breast Cancer
NCT02928978Ruxolitinib for Premalignant Breast Disease
NCT05501704ETHAN - ET for Male BC
NCT04584255Niraparib + Dostarlimab In BRCA Mutated Breast Cancer
NCT00146536Upstaging of ALH/LCIS Found on Core Biopsy Based on Subsequent Excisional Biopsy
NCT04443348Pre-op Pembro + Radiation Therapy in Breast Cancer (P-RAD)
NCT03400254Gedatolisib, Hydroxychloroquine or the Combination for Prevention of Recurrent Breast Cancer ("GLACIER")
NCT04841148Avelumab or Hydroxychloroquine With or Without Palbociclib to Eliminate Dormant Breast Cancer
NCT02457910Taselisib and Enzalutamide in Treating Patients With Androgen Receptor Positive Triple-Negative Metastatic Breast Cancer
NCT00925652Bevacizumab, Metronomic Chemotherapy (CM), Diet and Exercise After Preoperative Chemotherapy for Breast Cancer
NCT03368729Niraparib in Combination With Trastuzumab in Metastatic HER2+ Breast Cancer
NCT03095352Pembrolizumab With Carboplatin Compared to Carboplatin Alone in Breast Cancer Patients With Chest Wall Disease
NCT05721248STOP-HER2: Stopping Trastuzumab in HER2+ MBC
NCT03971409Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Stage IV or Unresectable, Recurrent Triple Negative Breast Cancer
NCT03501979Tucatinib, Trastuzumab, and Capecitabine for the Treatment of HER2+ LMD
NCT01101425Male Breast Cancer: Understanding the Biology for Improved Patient Care
NCT02551263Eribulin Treatment as 1st-line or 2nd-line Chemotherapy for HER2-negative Hormone-resistant Inoperable or Recurrent Metastatic Breast Cancer